● TheNasdaqComposite fell roughly 1.25% and the Philadelphia Semiconductorindexdeclined as much as 4%.
● TheNasdaqComposite fell about 1.25% amid a pronounced selloff in semiconductor and large-cap technology shares.
Picard Medical (NYSEAMERICAN:PMI) was indicated down 3.41% in the October 9, 2026 premarket session on the screener, on a listed price of USD 9.68 and premarketVolumeof 497 shares. The screener tags the catalyst as share issuance, but a search found no company release or …
Basel Medical Group (NASDAQ:BMGL) was indicated down 8.06% in the October 9, 2026 premarket session on the screener, on a listed price of USD 3.60 and premarketVolumeof 12,507 shares. The listed price is the October 8 close, when the shares rose about 9.76% from …
bioAffinity Technologies (NASDAQ:BIAF) was indicated down 5.85% in the October 9, 2026 premarket session on the screener, on a listed price of USD 5.64 and premarketVolumeof 13,667 shares. The screener tags an other event. A published headline list shows that on October 8 the …
DataMEDS AI (NASDAQ:MEDS) was indicated down 5.29% in the October 9, 2026 premarket session on the screener, on a listed price of USD 3.40 and premarketVolumeof 17,377 shares. The listed price is the October 8 close, when the shares rose USD 0.52, or 18.06%. …
Nexalin Technology (NASDAQ:NXL) was indicated down 5.11% in the October 9, 2026 premarket session on the screener, on a listed price of USD 4.11 and premarket volume of 580 shares. The screener lists no catalyst and a search found no company release or filing …
Veradermics (NYSE:MANE) shares rose roughly 14% to 16% on October 8, 2026, to between USD 126.63 and USD 128.85, according to market data in the topics file. No company news, filing or analyst note that explains the rise was identified. The file lists the …
China SXT Pharmaceuticals (NASDAQ:SXTC) fell about 88% on October 8, 2026 after announcing a registered direct offering at USD 1.50 per share. The topics file lists it as the top loser of the day and classes the offering terms as reported from a release …
Solid Biosciences (NASDAQ:SLDB) was indicated up 5.72% in the October 9, 2026 premarket session on the screener, on a listed price of USD 6.82 and premarket volume of 1,482 shares. The screener lists no catalyst, and a search found no company announcement or filing …